| mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
0.9 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
| mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
1 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |
| mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
1 |
| mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
1 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0019 |
1 |
| mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |
| mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
-0.0017 |
1 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.0015 |
1 |